Competitive inhibition of organic anion transporting polypeptide 1c1-mediated thyroxine transport by the fenamate class of nonsteroidal antiinflammatory drugs

Endocrinology

Volumn 150, Issue 2, 2009, Pages 1025-1032

  Westholm, Daniel E ^a   Stenehjem, David D ^a   Rumbley, Jon N ^a   Drewes, Lester R ^a   Anderson, Grant W ^a,b  

^a UNIVERSITY OF MINNESOTA DULUTH   (United States)

^b 232 Life Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BILIRUBIN; DICLOFENAC; FENAMIC ACID DERIVATIVE; FLURBIPROFEN; IBUPROFEN; INDOCYANINE GREEN; INDOMETACIN; IODINE 125; IOPANOIC ACID; MECLOFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1C1; PHENYTOIN; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; EX VIVO STUDY; GENETIC TRANSFECTION; HORMONE BLOOD LEVEL; HORMONE TRANSPORT; HUMAN; HUMAN CELL; IC 50; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CELLS, CULTURED; CLONING, MOLECULAR; FENAMATES; HUMANS; MICROVESSELS; MODELS, BIOLOGICAL; ORGANIC CATION TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; THYROXINE; TRANSFECTION;

EID: 59649083811     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0188     Document Type: Article

References (41)

1. Hagenbuch B, Meier PJ 2003 The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 1609:1-18
2. Meier-Abt F, Mokrab Y, Mizuguchi K 2005 Organic anion transporting polypeptides of the OATP/SLCO superfamily: identification of new members in nonmammalian species, comparative modeling and a potential transport mode. J Membr Biol 208:213-227
3. Hagenbuch B, Meier PJ 2004 Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653-665
4. Li L, Lee TK, Meier PJ, Ballatori N 1998 Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J Biol Chem 273:16184-16191
5. Gao B, Huber RD, Wenzel A, Vavricka SR, Ismair MG, Reme C, Meier PJ 2005 Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium. Exp Eye Res 80:61-72
6. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, Meier PJ 2002 Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol 16:2283-2296
7. Chu C, Li JY, Boado RJ, Pardridge WM 2008 Blood-brain barrier genomics and cloning of a novel organic anion transporter. J Cereb Blood Flow Metab 28:291-301
8. Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H, Sugiyama Y 2003 Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem 278:43489-43495
9. Jones SA, Thoemke KR, Anderson GW 2005 The role of thyroid hormone in fetal and neonatal brain development. Curr Opin Endocrinol Diabetes Obes 12:10-16
10. Kusuhara H, Sugiyama Y 2005 Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx 2:73-85
11. Westholm DE, Rumbley JN, Salo DR, Rich TP, Anderson GW 2008 Organic anion-transporting polypeptides at the blood-brain and blood-cerebrospinal fluid barriers. Curr Top Dev Biol 80:135-170
12. Tohyama K, Kusuhara H, Sugiyama Y 2004 Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 145:4384-4391
13. Enerson BE, Drewes LR 2006 The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 26:959-973
14. Anderson GW 2001 Thyroid hormones and the brain. Front Neuroendocrinol 22:1-17
15. Segal MB 2000 The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell Mol Neurobiol 20:183-196
16. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ 2001 Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22:451-476
17. Inoue M, Kinne R, Tran T, Arias IM1984 Taurocholate transport by rat liver canalicular membrane vesicles. Evidence for the presence of an Na +-indepen- dent transport system. J Clin Invest 73:659-663
18. Chalmers DK, Scholz GH, Topliss DJ, Kolliniatis E, Munro SL, Craik DJ, Iskander MN, Stockigt JR 1993 Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity. J Med Chem 36:1272-1277
19. Vane SJ 2000 Aspirin and other anti-inflammatory drugs. Thorax55(Suppl 2):S3-S9
20. Battaglia E, Gollan J 2001 A unique multifunctional transporter translocates estradiol-17/3-glucuronide in rat liver microsomal vesicles. J Biol Chem 276:23492-23498
21. Yarim M, Moro S, Huber R, Meier PJ, Kaseda C, Kashima T, Hagenbuch B, Folkers G 2005 Application of QSAR analysis to organic anion transporting polypeptide 1a5 (Oatp1a5) substrates. Bioorg Med Chem 13:463-471
22. Habgood MD, Begley DJ, Abbott NJ 2000 Determinants of passive drug entry into the central nervous system. Cell Mol Neurobiol 20:231-253
23. Parepally JM, Mandula H, Smith QR 2006 Brain uptake of nonsteroidal anti- inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharm Res 23:873-881
24. Chen Y, Dalwadi G, Benson HA 2004 Drug delivery across the blood-brain barrier. Curr Drug Deliv 1:361-376
25. Shitara Y, Sugiyama D, Kusuhara H, Kato Y, Abe T, Meier PJ, Itoh T, Sugiyama Y 2002 Comparative inhibitory effects of different compounds onratoatpl(slc21a1)- andOatp2(Slc21a5)-mediatedtransport. PharmRes 19:147-153
26. Parfenova H, Eidson TH, Leffler CW 1997 Upregulation of COX-2 in cerebral microvascular endothelial cells by smooth muscle cell signals. Am J Physiol 273(1 Pt 1):C277-C288
27. Parfenova H, Parfenov VN, Shlopov BV, Levine V, Falkos S, Pourcyrous M, Leffler CW2001 Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells. Am J Physiol Cell Physiol 281:C166-C178
28. Parfenova H, Levine V, Gunther WM, Pourcyrous M, Leffler CW 2002 COX-1 and COX-2 contributions to basal and IL-1 β-stimulated prostanoid synthesis in human neonatal cerebral microvascular endothelial cells. Pediatr Res 52:342-348
29. Glasgow JF, Middleton B 2001 Reye syndrome-insights on causation and prognosis. Arch Dis Child 85:351-353
30. Topliss DJ, Kolliniatis E, Barlow JW, Lim CF, Stockigt JR 1989 Uptake of 3,5,3' -triiodothyronine by cultured rat hepatoma cells is inhibitable by nonbile acid cholephils, diphenylhydantoin, and nonsteroidal antiinflammatory drugs. Endocrinology 124:980-986
31. Coppola A, Hughes J, Esposito E, Schiavo L, Meli R, Diano S 2005 Suppression of hypothalamic deiodinase type II activity blunts TRH mRNA decline during fasting. FEBS Lett 579:4654-4658
32. Bal CS, Kumar A, Chandra P 2005 Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial. J Clin Endocrinol Metab 90:6536-6540
33. Smith PJ, Surks MI 1984 Multiple effects of 5,5'-diphenylhydantoin on the thyroid hormone system. Endocr Rev 5:514-524
34. Lim CF, Loidl NM, Kennedy JA, Topliss DJ, Stockigt JR 1996 Drug effects on triiodothyronine uptake by rat anterior pituitary cells in vitro. Exp Clin Endocrinol Diabetes 104:151-157
35. Cui Y, Konig J, Leier I, Buchholz U, Keppler D 2001 Hepatic uptake of bili- rubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276:9626-9630
36. Davies NM, Skjodt NM 2000 Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach. Clin Pharmacokinet 38:377-392
37. Product information 2003 Voltaren. East Hanover, NJ: Norvartis Pharmaceuticals Corp.
38. Meyer MC, Straughn AB, Mhatre RM, Shah VP, Chen ML, Williams RL, Lesko LJ 2001 Variability in the bioavailability ofphenytoin capsules in males and females. Pharm Res 18:394-397
39. Kennedy JM, van Rij AM 2006 Drug absorption from the small intestine in immediate postoperative patients. Br J Anaesth 97:171-180
40. Moss AA, Lin SK, Margules ER, Motson RW, Riegelman S 1979 Pharmacokinetics of iopanoic acid in the rhesus monkey: biliary excretion, plasma protein binding and biotransformation. Invest Radiol 14:171-176
41. Anderson GW, Schoonover CM, Jones SA 2003 Control of thyroid hormone action in the developing rat brain. Thyroid 13:1039-1056